Investors
Careers
Contact Us
About Us
Our Products
Our Pipeline
Our Technology
Stock
Nasdaq:
DEPO
Price:
3.49 +0.00
Volume:
66,633
20 minute delay
In The News
May 1, 2008
Depomed Reports First Quarter 2008 Financial Results
April 24, 2008
Depomed to Announce First Quarter 2008 Financial Results on May 1, 2008
April 8, 2008
Depomed Elects Karen A. Dawes to Board of Directors
April 7, 2008
Depomed Settles Patent Litigation Against IVAX
March 24, 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia